$0.00 EPS Expected for LABRADOR IRON ORE ROYALTY CORPORATION (LIF), Profile of 2 Analysts Covering Midatech Pharma PLC (LON:MTPH)

Analysts expect LABRADOR IRON ORE ROYALTY CORPORATION (TSE:LIF) to report $0.00 EPS on May, 1. About 13,778 shares traded. LABRADOR IRON ORE ROYALTY CORPORATION (TSE:LIF) has risen 28.26% since September 13, 2016 and is uptrending. It has outperformed by 18.34% the S&P500.

Among 2 analysts covering Midatech Pharma Plc (LON:MTPH), 2 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Midatech Pharma Plc had 29 analyst reports since July 23, 2015 according to SRatingsIntel. The firm has “Buy” rating given on Friday, March 10 by Panmure Gordon. The stock of Midatech Pharma PLC (LON:MTPH) has “Buy” rating given on Wednesday, May 18 by Panmure Gordon. The firm has “Buy” rating given on Monday, September 14 by Panmure Gordon. On Monday, December 14 the stock rating was maintained by Panmure Gordon with “Buy”. As per Friday, September 2, the company rating was maintained by Panmure Gordon. Panmure Gordon maintained Midatech Pharma PLC (LON:MTPH) on Wednesday, May 11 with “Buy” rating. The firm has “Buy” rating given on Friday, September 30 by N+1 Singer. The rating was maintained by N+1 Singer with “Buy” on Friday, January 20. The firm has “Buy” rating given on Monday, April 11 by Panmure Gordon. The stock of Midatech Pharma PLC (LON:MTPH) earned “Buy” rating by Panmure Gordon on Friday, September 30. See Midatech Pharma PLC (LON:MTPH) latest ratings:

04/04/2017 Broker: Panmure Gordon Rating: Buy Old Target: GBX 297.00 New Target: GBX 297.00 Maintain
04/04/2017 Broker: N+1 Singer Rating: Buy New Target: GBX 283.00 Maintain
10/03/2017 Broker: Panmure Gordon Rating: Buy Old Target: GBX 297.00 New Target: GBX 297.00 Maintain
20/01/2017 Broker: N+1 Singer Rating: Buy New Target: GBX 283.00 Maintain
20/01/2017 Broker: Panmure Gordon Rating: Buy Old Target: GBX 297.00 New Target: GBX 297.00 Maintain
22/11/2016 Broker: Panmure Gordon Rating: Buy Old Target: GBX 297.00 New Target: GBX 297.00 Maintain
31/10/2016 Broker: N+1 Singer Rating: Buy Old Target: GBX 283.00 New Target: GBX 283.00 Maintain
31/10/2016 Broker: Panmure Gordon Rating: Buy Old Target: GBX 380.00 New Target: GBX 297.00 Reinitiateds

About 1,318 shares traded. Midatech Pharma PLC (LON:MTPH) has declined 21.36% since September 20, 2016 and is downtrending. It has underperformed by 31.28% the S&P500.

Midatech Pharma PLC is an early-stage biopharmaceutical firm that focuses on commercializing and developing products in oncology and other therapeutic areas. The company has market cap of 55.76 million GBP. The Company’s divisions include Pipeline Research and Development, and Commercial. It currently has negative earnings. The Pipeline Research and Development segment seeks to develop products using the nanomedicine and sustained release technology platforms.

Among 5 analysts covering Labrador Iron Ore Royalty Corporation (TSE:LIF), 1 have Buy rating, 0 Sell and 4 Hold. Therefore 20% are positive. Labrador Iron Ore Royalty Corporation had 30 analyst reports since August 7, 2015 according to SRatingsIntel. The stock has “Sector Perform” rating by Scotia Capital on Tuesday, January 17. Credit Suisse maintained the shares of LIF in report on Wednesday, August 19 with “Neutral” rating. The stock of LABRADOR IRON ORE ROYALTY CORPORATION (TSE:LIF) has “Outperform” rating given on Friday, February 24 by RBC Capital Markets. On Friday, August 7 the stock rating was downgraded by Desjardins Securities to “Hold”. Scotia Capital maintained it with “Sector Perform” rating and $17 target in Friday, December 9 report. The firm has “Outperform” rating by RBC Capital Markets given on Friday, October 16. The stock of LABRADOR IRON ORE ROYALTY CORPORATION (TSE:LIF) has “Outperform” rating given on Thursday, October 20 by RBC Capital Markets. The firm has “Outperform” rating by RBC Capital Markets given on Wednesday, December 14. The firm has “Buy” rating by Canaccord Genuity given on Friday, September 4. The stock of LABRADOR IRON ORE ROYALTY CORPORATION (TSE:LIF) earned “Outperform” rating by Raymond James on Tuesday, September 8.